Chemoinformaics analysis of (R)-LINALYL-6-O-ALPHA-L-ARABINOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE
Molecular Weight | 448.509 | nRot | 9 |
Heavy Atom Molecular Weight | 412.221 | nRig | 14 |
Exact Molecular Weight | 448.231 | nRing | 2 |
Solubility: LogS | -1.479 | nHRing | 2 |
Solubility: LogP | -0.162 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
nHA | 10 | APOL | 67.0946 |
nHD | 6 | BPOL | 43.0595 |
QED | 0.241 |
Synth | 4.863 |
Natural Product Likeliness | 2.354 |
NR-PPAR-gamma | 0.026 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.609 |
Pgp-sub | 0.841 |
HIA | 0.966 |
CACO-2 | -5.512 |
MDCK | 0.000177339 |
BBB | 0.319 |
PPB | 0.480138 |
VDSS | 0.358 |
FU | 0.35882 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0.1 |
CYP2c19-inh | 0.006 |
CYP2c19-sub | 0.429 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.153 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.111 |
CYP3a4-inh | 0.018 |
CYP3a4-sub | 0.018 |
CL | 1.218 |
T12 | 0.254 |
hERG | 0.009 |
Ames | 0.23 |
ROA | 0.077 |
SkinSen | 0.029 |
Carcinogencity | 0.039 |
EI | 0.011 |
Respiratory | 0.036 |
NR-Aromatase | 0.045 |
Antiviral | Yes |
Prediction | 0.871134 |